Skip to main content

Tufts Medicine Selected by Centers for Medicare and Medicaid Services to Test Medicare Dementia Care Model

July 18, 2024

Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers

Today, Tufts Medicine announced they have been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers. Under CMS' Guiding an Improved Dementia Experience (GUIDE) Model, Tufts Medicine will be one of almost 400 participants building Dementia Care Programs (DCPs) across the country, working to increase care coordination and improve access to services and supports, including respite care, for people living with dementia and their caregivers.

"CMS is excited to partner with Tufts Medicine under the GUIDE Model," said CMS Administrator Chiquita Brooks-LaSure. "GUIDE is a new approach to how Medicare will pay for the care of people living with dementia. The GUIDE participants are envisioning new ways to support not only people living with dementia, but also to reduce strain on the people who care for them, so that more Americans can remain in their homes and communities, rather than in institutions."

Launched on July 1, 2024, the GUIDE Model will test a new payment approach for key supportive services furnished to people living with dementia, including: comprehensive, person-centered assessments and care plans; care coordination; 24/7 access to an interdisciplinary care team member or help line; and certain respite services to support caregivers. People with dementia and their caregivers will have the assistance and support of a Care Navigator to help them access clinical and non-clinical services such as meals and transportation through community-based organizations.

"We are thrilled to have been chosen by CMS to participate in the groundbreaking GUIDE program," said Brent Forester, MD, Director of Behavioral Health for Tufts Medicine, Psychiatrist-in-Chief, Chairman of the Department of Psychiatry and Interim Chairman of the Department of Neurology at Tufts Medical Center, and the Dr. Frances S. Arkin Chair in Psychiatry at Tufts University School of Medicine. "Facing our current challenges of rising dementia prevalence, substantial delays in diagnosis, and tremendous healthcare access disparities, GUIDE represents an opportunity to implement a collaborative model to optimize care for people with dementia and support their families, as core components of a holistic approach to dementia care."

Tufts Medicine's participation in the GUIDE Model will help people living with dementia and their caregivers have access to education and support, such as training programs on best practices for caring for a loved one living with dementia. The GUIDE Model also provides respite services for certain people, enabling caregivers to take temporary breaks from their caregiving responsibilities. Respite is being tested under the GUIDE Model to assess its effect on helping caregivers continue to care for their loved ones at home, preventing or delaying the need for facility care.

GUIDE Participants represent a wide range of health care providers, including large academic medical centers, small group practices, community-based organizations, health systems, hospice agencies, and other practices.

This model delivers on a promise in the Biden Administration's Executive Order on Increasing Access to High-Quality Care and Supporting Caregivers and aligns with the National Plan to Address Alzheimer's Disease. 
 

Learn more about the CMS' GUIDE Model

Press Releases
Dr. Brent P. Forester To Lead Behavioral Health for Tufts Medicine
Brent P. Forester, MD, MSc. joined the Tufts Medicine family as Psychiatrist-in-Chief and Chairman for the Department of Psychiatry at Tufts Medical Center, Director of Behavioral Health for Tufts Medicine and Professor of Psychiatry and the Dr. Francis S. Arkin Chair of Psychiatry at Tufts University School of Medicine.
Press Releases
Study: Synthetic THC May Reduce Agitation in Patients with Alzheimer’s Dementia
The drug was found to be safe and well-tolerated; positive impact on patients helped reduce caregiver stress.
Healthy Podcast
Caring for Those With Dementia – Drs. Brent Forester and James Lech
Dementia is known a family disease because of the ways it affects not only the person, but also friends and family who are caregivers.

Be among the first to know

Enjoy the latest health updates from Tufts Medicine by signing up for our e-newsletter today.

Jump back to top